Independent Medical Education
Roche's Independent Medical Education grant supports unbiased, accredited programs advancing clinician knowledge in Parkinson’s Disease and KRAS G12C+ NSCLC to improve patient care.
Funder: Roche
Due Dates: August 19, 2026 (Parkinson's Disease CGN) | September 16, 2026 (KRAS G12C+ NSCLC RFP)
Funding Amounts: Up to $150,000 (Parkinson's Disease) | Up to $225,000 (KRAS G12C+ NSCLC); one-year project period typical
Summary: Supports independent, accredited medical education initiatives to enhance healthcare professional knowledge and improve patient outcomes in specified disease areas.
Key Information: U.S.-based accredited providers only; strict independence and firewall requirements apply.
Description
This opportunity provides grant support for independently developed, accredited medical education activities aimed at advancing healthcare professional knowledge and ultimately improving patient outcomes. Funded by Roche (Genentech), the program emphasizes the independence of educational content, with a strict policy against funder involvement in agenda or content development. For 2026, the calls focus on Parkinson’s Disease (CGN) and KRAS G12C+ NSCLC (RFP), targeting educational gaps identified in these areas. Programs must be evidence-based, unbiased, and designed to address bona fide educational needs in accordance with ACCME and other relevant standards.
